RBM10 is frequently downregulated in lung, colorectal, pancreatic and endometrial cancers (150, 153, 154, 155, 156) and loss of function mutations have been identified in lung adenocarcinoma (153, 157). This evidence concerns the gene RBM10 and lung adenocarcinoma.